FindMyKOL
Clinical trialNCT02552238CompletedPhase 3Interventional

Evaluation of Safety and Efficacy of Lumason/SonoVue in Subjects Undergoing Pharmacologic Stress BR1-142

SponsorBracco Diagnostics, IncEnrollment174Coronary Artery Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study was to assess the safety and efficacy of Lumason-enhanced dobutamine stress echo (DSE) in subjects having a suboptimal left ventricular endocardial border delineation (LV EBD) at rest and who were scheduled for coronary angiography.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belgium
  • Cliniques Universitaires Saint-Luc Unité de Pathologie Cardio-Vasculaire / Cardiologie

    Brussels, Belgium

  • Antwerp University Hospital

    Edegem, Belgium

Canada
  • St. Michael'S Hospital

    Toronto, Ontario, Canada

United Kingdom
  • Northwick Park Hospital

    Harrow, Middlesex, United Kingdom

  • Hammersmith Hospital

    London, United Kingdom

United States
  • Coastal Multi-Specialty Research, Coastal Heart Medical Group

    Santa Ana, California, United States

  • Alfieri Cardiology

    Wilmington, Delaware, United States

  • Homestead Cardiac and Vein Center

    Homestead, Florida, United States

  • Ochsner Clinic Foundation

    New Orleans, Louisiana, United States

  • St. Louis University Hospital

    St Louis, Missouri, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Duke University Medical Center Cardiac Diagnostic Unit

    Durham, North Carolina, United States

  • University of Texas Medical Branch at Galveston

    Galveston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
12 Oct 2015
Primary completion
22 Jun 2017
Completion
25 Feb 2018
Last update posted
7 Jul 2021
Registered enrollment
174
Registry id
NCT02552238

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.